32669-06-0Relevant articles and documents
Scouting new sigma receptor ligands: Synthesis, pharmacological evaluation and molecular modeling of 1,3-dioxolane-based structures and derivatives
Franchini, Silvia,Battisti, Umberto Maria,Prandi, Adolfo,Tait, Annalisa,Borsari, Chiara,Cichero, Elena,Fossa, Paola,Cilia, Antonio,Prezzavento, Orazio,Ronsisvalle, Simone,Aricò, Giuseppina,Parenti, Carmela,Brasili, Livio
, p. 1 - 19 (2016/02/19)
Herein we report the synthesis and biological activity of new sigma receptor (σR) ligands obtained by combining different substituted five-membered heterocyclic rings with appropriate σR pharmacophoric amines. Radioligand binding assay, performed on guine
Linker arms for nanocrystals and compounds thereof
-
, (2008/06/13)
A nanocrystal compound comprising: a nanocrystal, and attached thereto a compound of the following formula: n is 0 or an integer from 1 to 48; X and Z are independently O, NH, N—R, S, CH2, CO, COHN, NHCO, SO, SO2NH, NHSO2, carbamate and thio carbamate; R is alkyl or aryl; r is 0 or an integer from 1 to 15; and wherein S is the attachment point to a nanocrystal compound. The nanocrystal compounds of the present invention are useful fluorescent labels.
Development of novel, potent, and selective dopamine reuptake inhibitors through alteration of the piperazine ring of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909)
Matecka, Dorota,Rothman, Richard B.,Radesca, Lilian,De Costa, Brian R.,Dersch, Christina M.,Partilla, John S.,Pert, Agu,Glowa, John R.,Wojnicki, Francis H. E.,Rice, Kenner C.
, p. 4704 - 4716 (2007/10/03)
The design, synthesis, and biological evaluation of compounds related to the dopamine (DA) uptake inhibitors: 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine (1) and 1-[2-[bis-(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (2) (GBR